Double-blind placebo-controlled study of velnacrine in Alzheimer's disease

“Mini-mental state”

1975 • 82,784 citations

Clinical diagnosis of Alzheimer's disease

1984 • 27,279 citations

ECDEU Assessment Manual for Psychopharmacology

1976 • 8,729 citations

A new rating scale for Alzheimer's disease

1984 • 3,948 citations

Alzheimer's Disease and Senile Dementia: Loss of Neurons in the Basal Forebrain

1982 • 3,563 citations

Prevalence of Alzheimer's disease in a community population of older persons. Higher than previously reported

1989 • 1,630 citations

Pathological verification of ischemic score in differentiation of dementias

1980 • 1,259 citations

Some morphometric aspects of the brain in senile dementia of the alzheimer type

1981 • 803 citations

A Double-Blind, Placebo-Controlled Multicenter Study of Tacrine for Alzheimer's Disease

1992 • 618 citations

A controlled trial of tacrine in Alzheimer's disease. The Tacrine Study Group

1992 • 539 citations

Cell loss in the locus coeruleus in senile dementia of Alzheimer type

1981 • 443 citations

THE INVESTIGATION OF DEMENTIA: RESULTS IN 200 CONSECUTIVE ADMISSIONS

1981 • 229 citations

Cortical cholinergic fibers in aging and Alzheimer's disease: A morphometric study

1989 • 198 citations

Neuronal pathology in the nucleus basalis and associated cell groups in senile dementia of the Alzheimer's type

1985 • 157 citations

A comparison of changes in the nucleus basalis and locus caeruleus in Alzheimer's disease.

1984 • 117 citations

9-Amino-1,2,3,4-tetrahydroacridin-1-ols. Synthesis and evaluation as potential Alzheimer's disease therapeutics

1989 • 103 citations

Effect of scopolamine and HP 029, a cholinesterase inhibitor, on long-term potentiation in hippocampal slices of the guinea pig

1989 • 76 citations

Alzheimer plaques and cortical cholinergic innervation

1986 • 62 citations

Evaluation of HP 029 (Velnacrine Maleate) in Alzheimer's Diseasea

1991 • 50 citations

Multiple Dose Pharmacokinetics, Safety, and Tolerance of Velnacrine (HP 029) in Healthy Elderly Subjects: A Potential Therapeutic Agent for Alzheimer's Disease

1990 • 29 citations

Single Dose Safety, Tolerance, and Pharmacokinetics of HP 029 in Healthy Young Men: A Potential Alzheimer Agent

1989 • 27 citations

Muscarinic receptors and novel strategies for the treatment of age-related brain disorders

1994 • 25 citations